Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial

Piltin, M. A., Norwood, P., Ladores, V., Mukhtar, R. A., Sauder, C. A., Golshan, M., Tchou, J., Rao, R., Lee, M. C., Son, J., Reyna, C., Hewitt, K., Kuerer, H., Ahrendt, G., Greenwalt, I., Tseng, J., Postlewait, L., Howard-McNatt, M., … Jaskowiak, N. (2024). Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-024-15708-9
Authors:
Mara A Piltin
Peter Norwood
Velle Ladores
Rita A Mukhtar
Candice A Sauder
Mehra Golshan
Julia Tchou
Roshni Rao
Marie Catherine Lee
Jennifer Son
Chantal Reyna
Kelly Hewitt
Henry Kuerer
Gretchen Ahrendt
Ian Greenwalt
Jennifer Tseng
Lauren Postlewait
Marissa Howard-McNatt
Nora Jaskowiak
Laura J Esserman
Judy C Boughey
Affiliated Authors:
Roshni Rao
Publication Type:
Article
Unique ID:
10.1245/s10434-024-15708-9
PMID:
Publication Date:
Data Source:
PubMed

Record Created: